PMCB
PharmaCyte Biotech, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.45
+5.02%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$0.41
From 52W high−63.50%
Volume467160.00
Market cap$4.78M
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataSep 18, 2026
Open
$0.41
From 52W high
−63.50%
Volume
467160.00
Market cap
$4.78M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
4.4x
P/E (TTM)
—
RSI (14)
39.5
MomentumView details →
1D Return
+5.02%
YTD Return
−38.56%
SummaryUpdated Jul 1, 2026
PharmaCyte Biotech, Inc. (OTCQB:PMCB) is a biotechnology company founded in 1996 and headquartered in Las Vegas, Nevada. Originally incorporated as Nuvilex, Inc., the company changed its name to PharmaCyte Biotech in January 2015 and went public in 2013. The company is a clinical-stage biotechnology firm focused on developing innovative cellular therapies for treating cancer, diabetes, and malignant ascites using its proprietary encapsulation technology platform.
Similar companies
Latest newsMore news →
No recent news for PMCB.